Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities

Clinical trial NCT04982900 · UNKNOWN

Trial details

NCT number: NCT04982900
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Primary Lung Cancers

Start date: 2021-10-01
Primary completion: 2022-08-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.